pharmaceuticals
South Korea’s pharmaceutical market to benefit rising clinical trial activity
The sector is projected to reach $40.6b in 2028.
5 hours ago
South Korea’s pharmaceutical market to benefit rising clinical trial activity
The sector is projected to reach $40.6b in 2028.
5 hours ago
Skills shortage hinders digital transformation in the pharma industry
Large and medium-sized companies view this as a greater concern compared to smaller enterprises.
1 day ago
Pharmaceutical firms eye multiple myeloma amidst rising incidence rates
The increase has been faster in women since 2000.
6 days ago
South Korea’s pharmaceutical sales to hit $40.6b by 2028
It is expected to rise at a compound annual growth rate of 10% in US dollar terms.
7MM Parkinson’s disease pipeline focuses on disease-modifying agents
There are a total of 93 products in Phase I-III development for PD treatment.
India’s pharmaceutical sector faces challenges amidst weak IP regime
Applicants seeking market approval encounter uncoordinated processes amongst federal and state agencies.
Mainland China’s pharmaceutical sales to hit $345b by 2033
Global drugmakers seek partnerships to boost their presence in the world's second-largest pharmaceutical market.
SingHealth launches new College of Clinical Pharmacy
It will focus on areas such as precision medicine, digital health, and medical humanities.
India-based drugmakers urged to improve standards amidst quality scrutiny
This follows cases of drug toxicity, resulting in fatalities in Central Asia, North America, and Africa.
What factors drive the hormone replacement therapy market?
One key factor is the growing ageing population, particularly in developed countries.
China emerges as key player in oncology with antibody-drug conjugates surge
It represents 82% of the ADC pipeline in major APAC markets.
Atopic dermatitis market to reach $16.7b by 2030 across seven major markets
Pharmaceutical firms are urged to capitalise on current trends in AD trials.
Sepsis drug development remains challenged amidst high trial failures
Currently, there are 14 drugs in late-stage development across eight major markets.
Pakistan's pharmaceutical sector faces hurdles despite economic zone plans
It is expected to grow at a slower rate compared to neighbouring South Asian markets.
Mass spectrometry market to rise at 12.26% CAGR through 2028
Thanks to an increased investment in pharmaceutical and biopharmaceuticals.
Chinese health firms to see ‘limited impact’ from possible online drug sales rules
These firms have licences and are involved with self-operated pharmacies.
Rise in Indian medicine exports may cause patent woes in Australia: Fitch
India's weak IP laws could be an issue for drug manufacturers in Australia.